Direct-to-consumer sales emerges as the largest revenue segment
First written in FY2016. 15 of 26 entries say "Restated". Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1ReframedAnnual report
「Cosmetics business: ¥539.134 million; Beauty & Wellness business: ¥429.471 million; Regenerative Medicine-related business: ¥253.841 million; Sustainable business: ¥0.919 million; Market Expansion business: ¥1.044 million; Investment business: ¥19.999 million; AI & Technology business: ¥21.538 million」
Following the reorganization into 7 segments, the Cosmetics business became the largest revenue segment, with revenue of ¥539.134 million, changing the previous comparison centered on the Beauty & Wellness business. - FY2025-H1ReframedAnnual report
「Cosmetics business: ¥439.488 million; Beauty & Wellness business: ¥500.413 million; Regenerative Medicine-related business: ¥180.806 million; Sustainable business: ¥3.203 million」
Following the division of the reportable segments, the Beauty & Wellness business, rather than the previous combined presentation, became the largest of the 4 segments, with revenue of ¥500.413 million. The Cosmetics business generated ¥439.488 million, clarifying the comparison with the largest segment. - FY2024-Q3RestatedAnnual report
「In the Beauty & Wellness products jointly developed with celebrities, sales through new channels were strong. For cosmetics products, the Company expected revenue to increase by developing new products, including quasi-drugs, and launching them in new markets. However, despite conducting sales promotions, demand recovered slowly. Revenue was ¥1,474.008 million, up 1.9% year on year, and the operating loss was ¥33.109 million, compared with a loss of ¥27.432 million in the same quarter of the previous year.」
The Cosmetics and Beauty & Wellness business maintained its position as the largest revenue segment among the 3 segments, with revenue of ¥1,474.008 million. However, the operating loss widened from the previous year. - FY2024-Q2RestatedAnnual report
「In the Beauty & Wellness products jointly developed with celebrities, sales through new channels were strong. For cosmetics products, the Company expected revenue to increase by developing new products, including quasi-drugs, and launching them in new markets. However, despite increasing promotional expenses to raise market awareness, demand for cosmetics products recovered slowly. Revenue was ¥933.841 million, down ¥73.024 million year on year, and the operating loss was ¥40.017 million, compared with an operating loss of ¥4.947 million in the same quarter of the previous year.」
The Cosmetics and Beauty & Wellness business generated the highest revenue among the 3 segments, at ¥933.841 million, but revenue declined and the operating loss widened from the same quarter of the previous year. - FY2024-Q1ReframedAnnual report
「Cosmetics / Beauty & Wellness business B2B revenue 335,758 59.5 B2C revenue 132,952 23.7 Regenerative Medicine-related business Other 92,924 16.4 Sustainable business Other 2,294 0.4」
The Cosmetics and Beauty & Wellness business, corresponding to the former direct-to-consumer business, continued to be the largest revenue segment among the 3 segments, with revenue of ¥468.710 million. The business name and basis of comparison have changed from before. - FY2022-Q2RestatedAnnual report
「The Group has the mail-order business as its single reportable segment, and has omitted segment-by-segment disclosures for the other businesses because they are not material.」
The direct-to-consumer business changed from being the largest among multiple businesses and continues to be treated as the Group's sole reportable segment. - FY2022-Q1RestatedAnnual report
「The Group has designated the direct-to-consumer business as its sole reportable segment and has omitted segment-specific information for the Other business because it is not material.」
The direct-to-consumer business changed from being the largest among multiple businesses and continues to be treated as the Group's sole reportable segment. - FY2021RestatedAnnual report
「The Group, comprising the Company, Pass Co., Ltd., and 3 subsidiaries, is primarily engaged in the direct-to-consumer business.」
Although the Group also includes the Other business, which handles microalgae, the direct-to-consumer business continues to be positioned as the Group's principal business, having changed from being the largest among multiple businesses. - FY2021-Q3RestatedAnnual report
「In addition, as the Group operates as a single segment, segment information has been omitted.」
Following the Company's exit from the blockchain-related business, the direct-to-consumer business remained the Group's sole reportable segment. - FY2021-Q2RestatedAnnual report
「As a result, net sales were ¥1,071 million, down ¥294 million from the same quarter of the previous year; the operating loss was ¥256 million, up ¥182 million; the ordinary loss was ¥259 million, up ¥180 million; and the quarterly loss attributable to owners of the parent was ¥258 million, up ¥176 million.」
While the single-segment structure consisting solely of the direct-to-consumer business continued, revenue for the cumulative second-quarter consolidated period was ¥1,071 million and the business recorded an operating loss of ¥256 million. - FY2021-Q1ReframedAnnual report
「The Company exited the blockchain-related business in February 2020. Accordingly, during the cumulative first-quarter consolidated period, it operated only the direct-to-consumer business.」
The direct-to-consumer business changed from being the largest revenue business among multiple businesses to the sole business following the Company's exit from the blockchain-related business. - FY2020-Q3RestatedAnnual report
「The direct-to-consumer business benefited from special demand for cleansing products in the previous fiscal year, but that effect disappeared from the cumulative third-quarter consolidated period. In addition, sales of the Company's own cosmetics-related products declined year on year through catalog, store, and China sales channels. Revenue was ¥1,843 million, down ¥842 million year on year, and the business recorded an operating loss of ¥29 million, compared with operating income of ¥132 million in the same quarter of the previous year.」
The direct-to-consumer business continued to be the largest revenue business, exceeding the blockchain-related business. However, revenue declined to ¥1,843 million, and the business swung from operating income to an operating loss. - FY2020-Q2RestatedAnnual report
「The direct-to-consumer business benefited from special demand for cleansing products in the previous fiscal year, but that effect disappeared from the cumulative second-quarter consolidated period. In addition, catalog sales stagnated and store sales remained weak for the Company's own cosmetics-related products. Revenue was ¥1,249 million, down ¥535 million year on year, and the business recorded an operating loss of ¥20 million, compared with operating income of ¥88 million in the same quarter of the previous year.」
The direct-to-consumer business recorded revenue of ¥1,249 million, exceeding the ¥116 million generated by the blockchain-related business, and remained the largest revenue business. However, it recorded an operating loss due in part to the disappearance of the special demand effect. - FY2020-Q1RestatedAnnual report
「The direct-to-consumer business benefited from special demand for cleansing products in the previous fiscal year, but that effect disappeared from the cumulative first-quarter consolidated period. In addition, sales of the Company's own cosmetics-related products, particularly through stores, remained weak. As a result, revenue was ¥570 million and the business recorded an operating loss of ¥10 million.」
The direct-to-consumer business continued to be the largest revenue business, exceeding the ¥50 million in revenue from the blockchain-related business. However, it recorded an operating loss as the special demand effect disappeared and store sales remained weak. - FY2019RestatedAnnual report
「As a result of the factors described above, the direct-to-consumer business benefited from a special demand effect for cleansing products and recorded revenue of ¥3,615 million, up ¥527 million year on year. However, operating income was ¥139 million, down ¥37 million year on year, due to increased staffing to strengthen the cosmetics-related business and higher selling expenses, including advertising costs.」
The direct-to-consumer business remained the largest revenue business of the 2 segments. Revenue increased, while operating income declined due to increased staffing and higher advertising costs. - FY2019-Q3RestatedAnnual report
「In the mail-order business, revenue increased because of the special-demand effect from cleansing products, as described above, while costs increased year on year because advertising expenses were used actively for catalogue sales of cosmetics and other activities. As a result, revenue was ¥2,686 million, an increase of ¥398 million year on year, and operating profit was ¥132 million, a decrease of ¥16 million year on year.」
Of the 2 reportable segments, the direct-to-consumer business generated revenue of ¥2,686 million and remained the largest revenue segment. Excluding the ¥45 million in revenue from the blockchain-related business, the direct-to-consumer business accounted for the majority of consolidated revenue. - FY2019-Q2ReframedAnnual report
「As a result of the factors described above, revenue from the direct-to-consumer business was ¥1,784 million, up ¥276 million year on year, and operating income was ¥88 million, up ¥17 million from the same quarter of the previous year.」
The number of reportable segments returned to 2 following the addition of the blockchain-related business, but the direct-to-consumer business generated all revenue and remained the largest revenue segment. - FY2019-Q1ReframedAnnual report
「As the Group operates as a single segment, the direct-to-consumer business, segment information has been omitted.」
The direct-to-consumer business changed from being the largest revenue business among multiple segments to the Group's sole reportable segment following the discontinuation and sale of businesses including the travel business. The previous comparison of it as the largest revenue segment has been revised to reflect a single-segment structure. - FY2018AdvancedAnnual report
「Revenue was ¥3,087 million, up ¥43 million year on year, and operating income was ¥176 million, compared with an operating loss of ¥39 million in the previous year.」
The direct-to-consumer business remained the largest revenue segment, with revenue increasing and the business turning from an operating loss to operating income. - FY2018-Q3AdvancedAnnual report
「Revenue was ¥2,287.662 million, up ¥28.519 million year on year, and operating income was ¥148.874 million, compared with an operating loss of ¥15.957 million in the same quarter of the previous year.」
The direct-to-consumer business remained the largest revenue segment and turned from an operating loss in the same quarter of the previous year to operating income. Revenue also increased year on year. - FY2018-Q2AdvancedAnnual report
「Revenue was ¥1,508.794 million, down ¥53.169 million year on year, and operating income was ¥70.978 million, up ¥56.536 million year on year.」
The direct-to-consumer business remained the largest revenue segment, recording revenue of ¥1,508.794 million and operating income of ¥70.978 million. Revenue declined because of a decrease in the number of customers, while profit increased year on year due to cost reductions from structural reforms. - FY2018-Q1AdvancedAnnual report
「Revenue was ¥765.801 million, and operating income was ¥32.922 million, compared with an operating loss of ¥2.725 million in the same quarter of the previous year.」
The direct-to-consumer business was the largest revenue segment, with revenue of ¥765.801 million, and turned from an operating loss in the same quarter of the previous year to operating income. - FY2017-Q3RestatedAnnual report
「Revenue from the direct-to-consumer business was ¥2,259.142 million, and its operating loss was ¥15.957 million.」
The direct-to-consumer business remained the largest revenue segment, with revenue of ¥2,259.142 million. However, it swung from operating income in the previous quarter to an operating loss, due in part to the impact of reviewing discount measures. - FY2017-Q2RestatedAnnual report
「Revenue from the direct-to-consumer business was ¥1,561.963 million, and operating income was ¥14.442 million.」
The direct-to-consumer business remained the largest revenue segment in the cumulative second-quarter consolidated period, with revenue of ¥1,561.963 million, and recorded operating income this time. - FY2017-Q1RestatedAnnual report
「Revenue from the direct-to-consumer business was ¥747.521 million, and its operating loss was ¥2.725 million.」
The direct-to-consumer business remained the largest revenue segment this quarter, with revenue of ¥747.521 million, exceeding the other reportable segments. It recorded an operating loss of ¥2.725 million. - FY2016First statedAnnual report
「Revenue from the direct-to-consumer business was ¥1,508.450 million, while the business recorded an operating loss of ¥126.965 million, mainly because of insufficient new-product launches and an inability to approach its target customers appropriately.」
The direct-to-consumer business recorded revenue of ¥1,508.450 million and an operating loss of ¥126.965 million. Consolidated headcount increased by 56 people following the addition of this business.